Why the Medibank (ASX:MPL) share price is higher today

The Medibank (ASX: MPL) share price is edging higher today as the company released news regarding a change in management.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance

Image source: Getty Images

The Medibank Private Ltd (ASX: MPL) share price is edging higher today following the announcement of a new CEO. Shares in the health insurance giant are currently 0.52% higher, trading at $2.90.


This morning, Medibank announced that David Koczkar has been appointed as the new company chief executive officer (CEO). However, investors will have to wait till 17 May to see their new man in action. The news comes as Craig Drummond, CEO for the last five years, is stepping down from his role.

While new to the role, Mr Koczkar is not new to the company and has been serving Medibank as chief customer officer.

Medibank said he had been “instrumental in the growth of the company” while overseeing some of the largest changes in the private health insurance sector in Australia. Accomplishments in his previous role include improved customer growth and retention, and product improvements.

Prior to joining Medibank, Mr Koczkar was the group chief commercial officer at Jetstar. He has more than 25 years of leadership experience in the finance and consulting industry.

Management comments

Regarding both his imminent role and the previous CEO, Mr Koczkar said:

For the last seven years, I have had the privilege of working to improve our relationship with our customers, their experience and enhancing the value that we provide them. I am thrilled to be able to continue this work.

I would also like to take this opportunity to thank Craig Drummond for his leadership of our company over the last five years. He leaves our company in a stronger position, and we all remain committed to realising the ambition outlined for our customers, our owners and our people.

Terms of the new role

So how much does the new Medibank CEO stand to earn? The release said Mr Koczkar would be paid a fixed sum of $1.5 million a year. This will be reviewed annually and the remuneration includes cash, salary benefits and super contributions.

Moreover, he will also receive short and long term incentives. Of up to 150% of his annual total fixed remuneration based on performance.

On the news, the Medibank share price is trading slightly higher, up 0.52%.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News